Copyright Reports & Markets. All rights reserved.

Global Glaucoma Medications Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Glaucoma Medications Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Glaucoma Medications Market Size Growth Rate by Product
      • 1.4.2 Prostaglandin Analogs
      • 1.4.3 Beta Blockers
      • 1.4.4 Alpha Agonists
      • 1.4.5 Carbonic Anhydrase Inhibitors
      • 1.4.6 Combined Medications
    • 1.5 Market by End User
      • 1.5.1 Global Glaucoma Medications Market Size Growth Rate by End User
      • 1.5.2 Open-angle Glaucoma
      • 1.5.3 Closed-angle Glaucoma
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Glaucoma Medications Market Size
      • 2.1.1 Global Glaucoma Medications Revenue 2014-2025
      • 2.1.2 Global Glaucoma Medications Sales 2014-2025
    • 2.2 Glaucoma Medications Growth Rate by Regions
      • 2.2.1 Global Glaucoma Medications Sales by Regions
      • 2.2.2 Global Glaucoma Medications Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Glaucoma Medications Sales by Manufacturers
      • 3.1.1 Glaucoma Medications Sales by Manufacturers
      • 3.1.2 Glaucoma Medications Sales Market Share by Manufacturers
      • 3.1.3 Global Glaucoma Medications Market Concentration Ratio (CR5 and HHI)
    • 3.2 Glaucoma Medications Revenue by Manufacturers
      • 3.2.1 Glaucoma Medications Revenue by Manufacturers (2014-2019)
      • 3.2.2 Glaucoma Medications Revenue Share by Manufacturers (2014-2019)
    • 3.3 Glaucoma Medications Price by Manufacturers
    • 3.4 Glaucoma Medications Manufacturing Base Distribution, Product Types
      • 3.4.1 Glaucoma Medications Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Glaucoma Medications Product Type
      • 3.4.3 Date of International Manufacturers Enter into Glaucoma Medications Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Glaucoma Medications Sales by Product
    • 4.2 Global Glaucoma Medications Revenue by Product
    • 4.3 Glaucoma Medications Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Glaucoma Medications Breakdown Data by End User

    6 North America

    • 6.1 North America Glaucoma Medications by Countries
      • 6.1.1 North America Glaucoma Medications Sales by Countries
      • 6.1.2 North America Glaucoma Medications Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Glaucoma Medications by Product
    • 6.3 North America Glaucoma Medications by End User

    7 Europe

    • 7.1 Europe Glaucoma Medications by Countries
      • 7.1.1 Europe Glaucoma Medications Sales by Countries
      • 7.1.2 Europe Glaucoma Medications Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Glaucoma Medications by Product
    • 7.3 Europe Glaucoma Medications by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Glaucoma Medications by Countries
      • 8.1.1 Asia Pacific Glaucoma Medications Sales by Countries
      • 8.1.2 Asia Pacific Glaucoma Medications Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Glaucoma Medications by Product
    • 8.3 Asia Pacific Glaucoma Medications by End User

    9 Central & South America

    • 9.1 Central & South America Glaucoma Medications by Countries
      • 9.1.1 Central & South America Glaucoma Medications Sales by Countries
      • 9.1.2 Central & South America Glaucoma Medications Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Glaucoma Medications by Product
    • 9.3 Central & South America Glaucoma Medications by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Glaucoma Medications by Countries
      • 10.1.1 Middle East and Africa Glaucoma Medications Sales by Countries
      • 10.1.2 Middle East and Africa Glaucoma Medications Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Glaucoma Medications by Product
    • 10.3 Middle East and Africa Glaucoma Medications by End User

    11 Company Profiles

    • 11.1 Pfizer
      • 11.1.1 Pfizer Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Pfizer Glaucoma Medications Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Pfizer Glaucoma Medications Products Offered
      • 11.1.5 Pfizer Recent Development
    • 11.2 Novartis
      • 11.2.1 Novartis Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Novartis Glaucoma Medications Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Novartis Glaucoma Medications Products Offered
      • 11.2.5 Novartis Recent Development
    • 11.3 bausch Lomb
      • 11.3.1 bausch Lomb Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 bausch Lomb Glaucoma Medications Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 bausch Lomb Glaucoma Medications Products Offered
      • 11.3.5 bausch Lomb Recent Development
    • 11.4 Laboratoire Riva
      • 11.4.1 Laboratoire Riva Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Laboratoire Riva Glaucoma Medications Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Laboratoire Riva Glaucoma Medications Products Offered
      • 11.4.5 Laboratoire Riva Recent Development
    • 11.5 Jamp Pharma
      • 11.5.1 Jamp Pharma Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Jamp Pharma Glaucoma Medications Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Jamp Pharma Glaucoma Medications Products Offered
      • 11.5.5 Jamp Pharma Recent Development
    • 11.6 Fresenius
      • 11.6.1 Fresenius Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Fresenius Glaucoma Medications Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Fresenius Glaucoma Medications Products Offered
      • 11.6.5 Fresenius Recent Development
    • 11.7 Teva Pharmaceutical?
      • 11.7.1 Teva Pharmaceutical? Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Teva Pharmaceutical? Glaucoma Medications Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Teva Pharmaceutical? Glaucoma Medications Products Offered
      • 11.7.5 Teva Pharmaceutical? Recent Development
    • 11.8 SANDOZ
      • 11.8.1 SANDOZ Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 SANDOZ Glaucoma Medications Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 SANDOZ Glaucoma Medications Products Offered
      • 11.8.5 SANDOZ Recent Development
    • 11.9 Greenstone
      • 11.9.1 Greenstone Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Greenstone Glaucoma Medications Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Greenstone Glaucoma Medications Products Offered
      • 11.9.5 Greenstone Recent Development
    • 11.10 Mylan
      • 11.10.1 Mylan Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Mylan Glaucoma Medications Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Mylan Glaucoma Medications Products Offered
      • 11.10.5 Mylan Recent Development
    • 11.11 GE Medical
    • 11.12 Mint Pharmaceuticals
    • 11.13 Laboratoires Thea
    • 11.14 Taj Pharmaceuticals
    • 11.15 Actavis
    • 11.16 APOTEX
    • 11.17 Sun Pharma

    12 Future Forecast

    • 12.1 Glaucoma Medications Market Forecast by Regions
      • 12.1.1 Global Glaucoma Medications Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Glaucoma Medications Revenue Forecast by Regions 2019-2025
    • 12.2 Glaucoma Medications Market Forecast by Product
      • 12.2.1 Global Glaucoma Medications Sales Forecast by Product 2019-2025
      • 12.2.2 Global Glaucoma Medications Revenue Forecast by Product 2019-2025
    • 12.3 Glaucoma Medications Market Forecast by End User
    • 12.4 North America Glaucoma Medications Forecast
    • 12.5 Europe Glaucoma Medications Forecast
    • 12.6 Asia Pacific Glaucoma Medications Forecast
    • 12.7 Central & South America Glaucoma Medications Forecast
    • 12.8 Middle East and Africa Glaucoma Medications Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Glaucoma Medications Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Glaucoma Medications market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Glaucoma Medications market based on company, product type, end user and key regions.

      This report studies the global market size of Glaucoma Medications in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Glaucoma Medications in these regions.
      This research report categorizes the global Glaucoma Medications market by top players/brands, region, type and end user. This report also studies the global Glaucoma Medications market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Pfizer
      Novartis
      bausch Lomb
      Laboratoire Riva
      Jamp Pharma
      Fresenius
      Teva Pharmaceutical?
      SANDOZ
      Greenstone
      Mylan
      GE Medical
      Mint Pharmaceuticals
      Laboratoires Thea
      Taj Pharmaceuticals
      Actavis
      APOTEX
      Sun Pharma

      Market size by Product
      Prostaglandin Analogs
      Beta Blockers
      Alpha Agonists
      Carbonic Anhydrase Inhibitors
      Combined Medications
      Market size by End User
      Open-angle Glaucoma
      Closed-angle Glaucoma

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Glaucoma Medications market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Glaucoma Medications market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Glaucoma Medications companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Glaucoma Medications submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Glaucoma Medications are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Glaucoma Medications market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now